234 related articles for article (PubMed ID: 27473519)
1. Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.
Frimpong JA; D'Aunno T; Helleringer S; Metsch LR
BMC Public Health; 2016 Jul; 16():666. PubMed ID: 27473519
[TBL] [Abstract][Full Text] [Related]
2. Addressing Barriers to On-site HIV and HCV Testing Services in Methadone Maintenance Treatment Programs in the United States: Findings From a National Multisite Qualitative Study.
Behrends CN; Kapadia SN; Schackman BR; Frimpong JA
J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):393-402. PubMed ID: 33346582
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.
Frimpong JA; D'Aunno T
Subst Abuse Treat Prev Policy; 2016 Apr; 11():13. PubMed ID: 27036115
[TBL] [Abstract][Full Text] [Related]
4. Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.
Frimpong JA; D'Aunno T; Helleringer S; Metsch LR
J Subst Abuse Treat; 2016 Apr; 63():46-53. PubMed ID: 26810130
[TBL] [Abstract][Full Text] [Related]
5. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.
Frimpong JA; D'Aunno T; Jiang L
Am J Public Health; 2014 Jun; 104(6):e75-82. PubMed ID: 24825236
[TBL] [Abstract][Full Text] [Related]
6. On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.
Frimpong JA; D'Aunno T; Perlman DC; Strauss SM; Mallow A; Hernandez D; Schackman BR; Feaster DJ; Metsch LR
Trials; 2016 Mar; 17(1):117. PubMed ID: 26936623
[TBL] [Abstract][Full Text] [Related]
7. HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations.
D'Aunno T; Pollack HA; Jiang L; Metsch LR; Friedmann PD
Health Serv Res; 2014 Feb; 49(1):230-48. PubMed ID: 23855724
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a Collaborative HIV and Hepatitis C Screening Program in Appalachian Urgent Care Settings.
Burrell CN; Sharon MJ; Davis SM; Wojcik EM; Martin IBK
West J Emerg Med; 2018 Nov; 19(6):1057-1064. PubMed ID: 30429942
[TBL] [Abstract][Full Text] [Related]
9. Missed opportunities for hepatitis C testing in opioid treatment programs.
Frimpong JA
Am J Public Health; 2013 Jun; 103(6):1028-30. PubMed ID: 23597374
[TBL] [Abstract][Full Text] [Related]
10. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
[TBL] [Abstract][Full Text] [Related]
11. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs.
Frimpong JA; Parish CL; Feaster DJ; Gooden LK; Nelson MC; Matheson T; Siegel K; Haynes L; Linas BP; Assoumou SA; Tross S; Kyle T; Liguori TK; Toussaint O; Annane D; Metsch LR
Trials; 2023 Sep; 24(1):609. PubMed ID: 37749635
[TBL] [Abstract][Full Text] [Related]
12. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.
Strauss SM; Astone JM; Jarlais DD; Hagan H
Drug Alcohol Depend; 2004 Mar; 73(3):227-36. PubMed ID: 15036545
[TBL] [Abstract][Full Text] [Related]
13. Program characteristics associated with testing for HIV and hepatitis C in veterans substance use disorder clinics.
McInnes DK; Hyun JK; Trafton JA; Asch SM; Gifford AL
Psychiatr Serv; 2010 Jan; 61(1):90-4. PubMed ID: 20044426
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department.
Hsieh YH; Rothman RE; Laeyendecker OB; Kelen GD; Avornu A; Patel EU; Kim J; Irvin R; Thomas DL; Quinn TC
Clin Infect Dis; 2016 May; 62(9):1059-65. PubMed ID: 26908800
[TBL] [Abstract][Full Text] [Related]
15. Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
Strauss SM; Astone JM; Des Jarlais DC; Hagan H
AIDS Patient Care STDS; 2005 Feb; 19(2):78-88. PubMed ID: 15716639
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
Bini EJ; Kritz S; Brown LS; Robinson J; Calsyn D; Alderson D; Tracy K; McAuliffe P; Smith C; Rotrosen J
J Subst Abuse Treat; 2012 Jun; 42(4):438-45. PubMed ID: 22035702
[TBL] [Abstract][Full Text] [Related]
17. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
[TBL] [Abstract][Full Text] [Related]
18. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
19. HIV and Hepatitis C Virus Screening Practices in a Geographically Diverse Sample of American Community Health Centers.
Mayer KH; Crawford P; Dant L; Gillespie S; Singal R; Vandermeer M; Muench J; Long T; Quach T; Chaudhry A; Crane HM; Lembo D; Mills R; McBurnie MA
AIDS Patient Care STDS; 2016 Jun; 30(6):237-46. PubMed ID: 27286294
[TBL] [Abstract][Full Text] [Related]
20. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units.
Strauss SM; Astone JM; Hagan H; Des Jarlais DC
J Urban Health; 2004 Mar; 81(1):38-47. PubMed ID: 15047782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
